Winners
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares rose 30.0% to $0.07 during Friday’s regular session.
- Can Fite Biopharma (AMEX:CANF) shares rose 29.17% to $0.23. The market value of their outstanding shares is $3.0 million.
- Greenwich Life Sciences (NASDAQ:GLSI) shares rose 25.21% to $21.55. The market value of their outstanding shares is $230.0 million.
- GridAI technologies (NASDAQ:GRDX) shares rose 18.08% to $3.01. The market value of their outstanding shares is $8.5 million.
- Inhibikase therapies (NASDAQ:IKT) shares rose 16.31% to $1.92. The market value of their outstanding shares is $200.0 million.
- SeaStar Medical Holding (NASDAQ:ICU) shares rose 15.24% to $0.28. The market value of their outstanding shares is $8.7 million.
Losers
- Dermata therapies (NASDAQ:DRMA) shares fell 18.5% to $1.93 during Friday’s regular session. The market value of their outstanding shares is $2.4 million.
- ProPhase laboratories (NASDAQ:PRPH) shares fell 15.47% to $0.52. The market value of their outstanding shares is $2.5 million.
- Regencell Biosciences (NASDAQ:RGC) shares fell 14.25% to $21.09. The company’s market capitalization is $12.1 billion.
- Q/C technologies (NASDAQ:QCLS) shares fell 11.12% to $4.56. The company’s market capitalization is $21.3 million.
- Propanc Biopharma (NASDAQ:PPCB) shares fell 10.44% to $0.59. The market value of their outstanding shares is $8.8 million.
- Akanda (NASDAQ:AKAN) shares fell 10.29% to $0.45.
See also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market news and data powered by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
#Healthcare #Stocks #Moving #Fridays #Intraday #Session #Akanda #NASDAQAKAN #Fite #Biofarma #AMEXCANF


